Literature DB >> 17660670

Morbidity and mortality in ESRD patients on dialysis.

Jamal S Al Wakeel1, Ahmed H Mitwalli, S Al Mohaya, Hassan Abu-Aisha, Nauman Tarif, Ghulam H Malik, D Hammad.   

Abstract

End-stage renal disease (ESRD), due to its high morbidity and mortality as well as social and financial implications, is a major public health problem. Outcome depends not only on different modalities of treatment like hemodialysis and peritoneal dialysis, but also on existing co-morbidities, age, duration on dialysis, supportive therapies and infection control strategies. Thus, a detailed study becomes necessary to improve health care delivery, provide medical care and to establish a geographical reference. The present study was undertaken to characterize the ESRD patients by their demographic and co-morbid conditions and relate this to the morbidity and mortality trends. The medical records of 110 ESRD patients seen over a five-year period (June 1995 to December 1999) in two tertiary-care hospitals in Riyadh, Saudi Arabia were studied retrospectively. There were 79 (64.5%) males and 31 (35.5%) females; their age ranged from 17 to 92 years (mean age 53.8 +/- 17.8 years). Diabetes was the commonest cause of ESRD seen in 26 (26.6%) followed by nephrosclerosis, unknown etiology, lupus nephritis, pyelonephritis and primary glomerulonephritis. Diabetes mellitus was the most prevalent co-morbidity seen during the study period and occurred in 65 patients (59%) followed by heart disease in 36 (32.7%), liver disease in 30 (27.3%), cerebrovascular accidents in 13 (11.8%) and neoplasm in 11 (10%). Seven (6.3%) patients only were smokers. Hemodialysis was the most frequent treatment choice as renal replacement therapy. Among the causes of hospitalization, cardiovascular conditions were the leading single cause (19.1%), followed by access related reasons and infections (11.5% each). The overall hospitalization rate was 11.2 days/year. The overall mortality rate was 8.07 deaths/year. The leading cause of death was cardiovascular in 15 (51.7%) followed by unknown/sudden death in eight (27.5%). Other causes of death included fluid overload, gastrointestinal hemorrhage, septicemia, liver disease and pulmonary embolism. Diabetes was the commonest co-morbid cause among the deceased. Old age, diabetes mellitus, prolonged duration on dialysis and cardiac diseases were the common causes of mortality. Our findings are consistent with worldwide reports. The study provides a reference data and will hopefully be helpful in improving the medical care.

Entities:  

Year:  2002        PMID: 17660670

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  10 in total

1.  Contemporary Trends and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction and End-Stage Renal Disease on Dialysis: Insight from the National Inpatient Sample.

Authors:  Muhammad Zia Khan; Moinuddin Syed; Mohammed Osman; Mohammed Faisaluddin; Samian Sulaiman; Peter D Farjo; Muhammad U Khan; Pratik Agrawal; Anas Alharbi; Safi U Khan; Muhammad Bilal Munir; Sudarshan Balla
Journal:  Cardiovasc Revasc Med       Date:  2020-05-11

2.  Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review.

Authors:  Amal A Hassanien; Fahdah Al-Shaikh; Eszter P Vamos; Ghasem Yadegarfar; Azeem Majeed
Journal:  JRSM Short Rep       Date:  2012-06-15

Review 3.  Diabetes and end-stage renal disease; a review article on new concepts.

Authors:  Seyed Bahman Ghaderian; Fatemeh Hayati; Shokouh Shayanpour; Seyed Seifollah Beladi Mousavi
Journal:  J Renal Inj Prev       Date:  2015-06-01

4.  Retrospective observational study examining indications for hospitalisation among haemodialysis patients at one of the Ministry of Health Hospitals in Makkah, Saudi Arabia.

Authors:  Amal A Hassanien; Azeem Majeed; Hilary Watt
Journal:  JRSM Open       Date:  2014-10-08

5.  Peritoneal dialysis related infections in a tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Somia M Alfayez; Shahd M Alsaqoub; Abeer Y Qattan; Mada A Alghamdi; Dalia S Elfeky; Fadel A Alrowaie; Doaa S Aljasser; Sadiqa B Syed
Journal:  Saudi Med J       Date:  2019-02       Impact factor: 1.484

6.  Investigation of the Impact of Endodontic Therapy on Survival among Dialysis Patients in Taiwan: A Nationwide Population-Based Cohort Study.

Authors:  Chih-Chien Chiu; Ya-Chieh Chang; Ren-Yeong Huang; Jenq-Shyong Chan; Chi-Hsiang Chung; Wu-Chien Chien; Yung-Hsi Kao; Po-Jen Hsiao
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

7.  Efficacy of Oral Administration of Allium sativum Powder "Garlic Extract" on Lipid Profile, Inflammation, and Cardiovascular Indices among Hemodialysis Patients.

Authors:  Masoumeh Asgharpour; Armin Khavandegar; Parastoo Balaei; Noora Enayati; Parham Mardi; Amirhesam Alirezaei; Mahmood Bakhtiyari
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.629

8.  Effect of exercise therapy on lipid parameters in patients with end-stage renal disease on hemodialysis.

Authors:  Lorenzo Gordon; Donovan A McGrowder; Yeiny T Pena; Elsa Cabrera; Marilyn Lawrence-Wright
Journal:  J Lab Physicians       Date:  2012-01

9.  Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study.

Authors:  Chih-Hung Guo; Pei-Chung Chen; Guoo-Shyng W Hsu; Chia-Liang Wang
Journal:  Nutrients       Date:  2013-04-22       Impact factor: 5.717

10.  Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.

Authors:  Muhammad Dzafir Ismail; Maisarah Jalalonmuhali; Zaid Azhari; Jeevitha Mariapun; Zhen-Vin Lee; Imran Zainal Abidin; Wan Azman Wan Ahmad; Ahmad Syadi Mahmood Zuhdi
Journal:  BMC Cardiovasc Disord       Date:  2018-09-24       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.